Literature DB >> 24608018

Percutaneous aortic balloon valvotomy in the United States: a 13-year perspective.

Apurva O Badheka1, Nileshkumar J Patel2, Vikas Singh3, Neeraj Shah2, Ankit Chothani4, Kathan Mehta5, Abhishek Deshmukh6, Abhijit Ghatak3, Ankit Rathod7, Harit Desai3, Ghanshyambhai T Savani3, Peeyush Grover3, Nilay Patel1, Shilpkumar Arora8, Cindy L Grines1, Theodore Schreiber1, Raj Makkar7, Charanjit S Rihal8, Mauricio G Cohen3, Eduardo De Marchena3, William W O'Neill9.   

Abstract

BACKGROUND: We determined the contemporary trends of percutaneous aortic balloon valvotomy and its outcomes using the nation's largest hospitalization database. There has been a resurgence in the use of percutaneous aortic balloon valvotomy in patients at high surgical risk because of the development of less-invasive endovascular therapies.
METHODS: This is a cross-sectional study with time trends using the Nationwide Inpatient Sample database between the years 1998 and 2010. We identified patients using the International Classification of Diseases, 9th Revision, Clinical Modification procedure code for valvotomy. Only patients aged more than 60 years with aortic stenosis were included. Primary outcome included in-hospital mortality, and secondary outcomes included procedural complications and length of hospital stay.
RESULTS: A total of 2127 percutaneous aortic balloon valvotomies (weighted n = 10,640) were analyzed. The use rate of percutaneous aortic balloon valvotomy increased by 158% from 12 percutaneous aortic balloon valvotomies per million elderly patients in 1998-1999 to 31 percutaneous aortic balloon valvotomies per million elderly patients in 2009-2010 in the United States (P < .001). The hospital mortality decreased by 23% from 11.5% in 1998-1999 to 8.8% in 2009-2010 (P < .001). Significant predictors of in-hospital mortality were the presence of increasing comorbidities (P = .03), unstable patient (P < .001), any complication (P < .001), and weekend admission (P = .008), whereas increasing operator volume was associated with significantly reduced mortality (P = .03). Patients who were admitted to hospitals with the highest procedure volume and the highest volume operators had a 51% reduced likelihood (P = .05) of in-hospital mortality when compared with those in hospitals with the lowest procedure volume and lowest volume operators.
CONCLUSION: This study comprehensively evaluates trends for percutaneous aortic balloon valvotomy in the United States and demonstrates the significance of operator and hospital volume on outcomes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complications; Hospital stay; Mortality; Percutaneous balloon aortic valvotomy

Mesh:

Year:  2014        PMID: 24608018     DOI: 10.1016/j.amjmed.2014.02.025

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Percutaneous balloon aortic valvuloplasty in the era of transcatheter aortic valve implantation: a narrative review.

Authors:  Thomas R Keeble; Arif Khokhar; Mohammed Majid Akhtar; Anthony Mathur; Roshan Weerackody; Simon Kennon
Journal:  Open Heart       Date:  2016-12-07

2.  Bioprosthetic aortic valve replacement 12 years after percutaneous aortic valvuloplasty in a young female adult with hope of pregnancy.

Authors:  Hirohiko Akutsu; Yuichiro Kaminishi; Soki Kurumisawa; Yoshio Misawa
Journal:  Acute Med Surg       Date:  2016-02-26

3.  Utility of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era.

Authors:  Luke Dawson; Alex Huang; Laura Selkrig; James A Shaw; Dion Stub; Antony Walton; Stephen J Duffy
Journal:  Open Heart       Date:  2020-04

4.  Gastrointestinal Bleeding in Patients With Acute Respiratory Distress Syndrome: A National Database Analysis.

Authors:  Faraz Siddiqui; Moiz Ahmed; Saqib Abbasi; Akshay Avula; Abdul Hasan Siddiqui; Jobin Philipose; Hafiz M Khan; Tahir M A Khan; Liliane Deeb; Michel Chalhoub
Journal:  J Clin Med Res       Date:  2018-12-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.